ROS-Suppression Nanoplatform Combined Activation of STAT3/Bcl-2 Pathway for Preventing Myocardial Infarction in Mice
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.3c16735 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Nan Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, 99 Longcheng Street…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Myocardial Infarction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Shanxi Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, 99 Longcheng Street, Taiyuan 030032, China.
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1037 Luoyu Road, Wuhan 430030, China.
- Cardiology Department, First Hospital of Shanxi Medical University, 85 Jiefang South Road, Taiyuan 030032, China.
- Department of Biochemistry and Molecular Biology, Shanxi Medical University, 56 Xinjian South Road, Taiyuan 030032, China.
- The First Clinical Medical College, Shanxi Medical University, 85 Jiefang South Road, Taiyuan 030001, China.
- The Radiology Department of Shanxi Provincial People's Hospital, The Fifth Hospital of Shanxi Medical University, Taiyuan 030001, China.
ORCID-Profile: Nan Hu, Shaodong Zhai, Ruiping Zhang
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Shanxi Province
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Bethune Hospital of Shanxi Medical University
- Key Laboratory of Nano-imaging and Drug-loaded Preparation of Shanxi Province
Zitieren
APA
Hu, N., Sun, M., Lv, N., Gao, Y., Fu, X., Xing, D., Guo, X., Zhai, S., & Zhang, R. (2024). ROS-Suppression Nanoplatform Combined Activation of STAT3/Bcl-2 Pathway for Preventing Myocardial Infarction in Mice. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c16735
Vancouver
Hu N, Sun M, Lv N, Gao Y, Fu X, Xing D, et al. ROS-Suppression Nanoplatform Combined Activation of STAT3/Bcl-2 Pathway for Preventing Myocardial Infarction in Mice. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.3c16735
BibTeX
@article{Hu2024,
author = {Hu, Nan and Sun, Meng and Lv, Nan and Gao, Yangyang and Fu, Xiaohong and Xing, Dayi and Guo, Xiang and Zhai, Shaodong and Zhang, Ruiping},
title = {ROS-Suppression Nanoplatform Combined Activation of STAT3/Bcl-2 Pathway for Preventing Myocardial Infarction in Mice},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.3c16735}
}
EUVIMED